Loading provider…
Loading provider…
Pediatrics Physician in NJ
NPI: 1285069948HQ Phone
Get D.O. Herbert's Phone Numberphone_androidMobile
Get D.O. Herbert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNJ State Medical License
Kansas City University of Medicine and Biosciences College of Osteopathic Medicine
Medical School
Until 1980
Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]).
Authors: Brian Hoh, Robert Macdonald
Publication Date: 2017-01
Authors: Eric Sauvageau, Jose Suarez, Sepideh Amin-Hanjani, Khaled Aziz, Gaurav Gupta, Andrew Carlson, Michael Diringer, Wayne Clark, Arun Amar, Babak Jahromi, Matthew Lawson, Pascal Jabbour
Journal: Stroke
Publication Date: 2020-03-06
Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)].
Authors: Michael Diringer
Publication Date: 2018-07-18